Population Pharmacokinetics of C1 Esterase Inhibitor Used to Treat Patients with Acute Hereditary Angioedema Attacks in a Multicenter, Randomized, Placebo-controlled Study (I.M.P.A.C.T.1)

Population Pharmacokinetics of C1 Esterase Inhibitor Used to Treat Patients with Acute Hereditary Angioedema Attacks in a Multicenter, Randomized, Placebo-controlled Study (I.M.P.A.C.T.1)

C1 esterase inhibitor (C1-INH) replacement therapy is the gold standard for treating acute attacks in hereditary angioedema (HAE).

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of allergy and clinical immunology 2010-02, Vol.125 (2), p.AB164-AB164
Hauptverfasser: Ritchie, B, Levy, R, Wasserman, R, Bewtra, A, Hurewitz, D, Obtulowicz, K, Reshef, A, Moldovan, D, Shirov, T, Grivcheva-Panovska, V, Bernstein, J, Kiessling, P, Schindel, F, Craig, T
Format: Artikel
Sprache:eng
Schlagworte:
Allergy and Immunology
Confidence intervals
Medical treatment
Population
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:C1 esterase inhibitor (C1-INH) replacement therapy is the gold standard for treating acute attacks in hereditary angioedema (HAE).
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2009.12.644